T:

Sarah Morin1,2, Filippo Boroli3, Sophie Vandenberghe-Durr4

  • 1Department of Oncology Division of Hematology Geneva University Hospitals Geneva Switzerland.

EJHaem
|June 19, 2024
PubMed
概括

严重的过敏反应是一种罕见但严重的不良事件,可以发生在化学抗原受体T (CAR-T) 细胞输液后. 这凸显了监测和管理CAR-T细胞治疗患者的过敏反应的必要性.